Compositions and methods for the treatment of immunomediated inflammatory disorders
US5525623A · kind A · utility
43Cited by
2References
118Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 1994 |
| Grant date | Jun 11, 1996 |
| Priority date | — |
| Expiry date | Mar 11, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for the prevention and treatment of immunomediated inflammatory disorders, especially for those disorders associated with the respiratory tract, are provided. More particularly, a tryptase inhibitor, typically a hydroxyaroyl or hydroxyheteroaroyl substituted dipeptide, is administered. Also provided by this invention are pharmaceutical compositions, typically aerosol or topical, as well as aerosol devices for administering these compositions intranasally.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.